Detalhe da pesquisa
1.
A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphoma.
Blood
; 138(6): 452-463, 2021 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33728448
2.
A novel prognostic index for sporadic Burkitt lymphoma in adult patients: a real-word multicenter study.
BMC Cancer
; 22(1): 45, 2022 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34996395
3.
Low initial trough concentration of rituximab is associated with unsatisfactory response of first-line R-CHOP treatment in patients with follicular lymphoma with grade 1/2.
Acta Pharmacol Sin
; 42(4): 641-647, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32737470
4.
Development of a highly efficient, strongly coupled organic light-emitting diode based on intracavity pumping architecture.
Opt Express
; 28(26): 39781-39789, 2020 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33379520
5.
Upfront autologous stem cell transplantation for untreated diffuse large B cell lymphoma patients in rituximab era: a systematic review and meta-analysis.
Ann Hematol
; 99(6): 1311-1319, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32285160
6.
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis.
Lancet Oncol
; 17(3): 389-400, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26873565
7.
Radical surgery may be not an optimal treatment approach for pulmonary MALT lymphoma.
Tumour Biol
; 36(8): 6409-16, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25801243
8.
Peripheral blood lymphocyte to monocyte ratio identifies high-risk adult patients with sporadic Burkitt lymphoma.
Ann Hematol
; 94(10): 1645-54, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26082333
9.
The prognostic nutritional index predicts survival for patients with extranodal natural killer/T cell lymphoma, nasal type.
Ann Hematol
; 94(8): 1389-400, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25869028
10.
Expression of BAFF-R, but not BAFF, is an independent prognostic factor in diffuse large B-cell lymphoma patients treated with R-CHOP.
Ann Hematol
; 94(11): 1865-73, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26327569
11.
Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival.
Chin J Cancer
; 34(5): 225-34, 2015 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26058465
12.
Three prognostic factors influence clinical outcomes of primary testicular lymphoma.
Tumour Biol
; 34(1): 55-63, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22965883
13.
Prognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphoma.
BMC Cancer
; 13: 222, 2013 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23638998
14.
Obinutuzumab Versus Rituximab Immunochemotherapy in Previously Untreated iNHL: Final Results From the GALLIUM Study.
Hemasphere
; 7(7): e919, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37404773
15.
Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphoma.
Cell Rep Med
; 4(2): 100859, 2023 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36812892
16.
Schedule-dependent inhibition of T-cell lymphoma cells by cotreatment with the mTOR inhibitor everolimus and anticancer drugs.
Invest New Drugs
; 30(1): 223-35, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20960030
17.
Serum beta2-microglobin is a predictor of prognosis in patients with upper aerodigestive tract NK/T-cell lymphoma.
Ann Hematol
; 91(8): 1265-70, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22373550
18.
High Ki-67 expression in diffuse large B-cell lymphoma patients with non-germinal center subtype indicates limited survival benefit from R-CHOP therapy.
Eur J Haematol
; 88(6): 510-7, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22413767
19.
EGFR inhibitors sensitize non-small cell lung cancer cells to TRAIL-induced apoptosis.
Chin J Cancer
; 30(10): 701-11, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21959047
20.
Cyclosporine, prednisone, and high-dose immunoglobulin treatment of angioimmunoblastic T-cell lymphoma refractory to prior CHOP or CHOP-like regimen.
Chin J Cancer
; 30(10): 731-8, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21959050